SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
239Wedbush PAC Grow Life Sciences .... OMER report today ..... PT raised to $44 ***Howard Williams-6/2/2014
238 Omeros Receives FDA Approval of Omidria™ for Use in Cataract and Other IntraocuHoward Williams-6/2/2014
237Ten months ago, 8/1/13 OMER PR ....... (my bold/underline) "SEATTLE, Aug. Howard Williams-5/30/2014
236New SeekingAlpha article out today http://seekingalpha.com/article/2238823-2nd-Howard Williams-5/27/2014
235New Wedbush Quick Note out today .... main new points are: *********************Howard Williams15/23/2014
234New 8-K today ... arranging a national Omidria sales staff *********************Howard Williams-5/22/2014
233Omeros (OMER) - A Seattle biotech New Wedbush report out ....... $37 12-month pHoward Williams-5/15/2014
232 Omeros Corporation Reports First Quarter 2014 Financial Results -- Secures AddiHoward Williams-5/12/2014
231Omidria ..... OMS302 ..... news http://www.thestreet.com/story/12669054 … _ven=Howard Williams-5/12/2014
230Medscape Medical News > Conference News Combination Drug Shown to Prevent MHoward Williams-5/7/2014
229 Investigational New Drug Application Cleared by FDA for OMS721 in Thrombotic MiHoward Williams-4/3/2014
228Ingalls & Snyder, LLC of New York just filed an SC 13G/A form, having acquirHoward Williams-4/1/2014
227 Omeros Invited to Present on OMS824 Phase 2 Clinical Program at the SchizophrenHoward Williams-4/1/2014
226A new and important point was made by Greg Demopulos this morning ........ a sinHoward Williams-3/28/2014
225Just a reminder .... Friday, early, OMER webcast Omeros to Present at BioCenturHoward Williams-3/27/2014
224Interesting option pricing comments by Alan Ross on Investor Village .... ******Howard Williams-3/27/2014
223Omeros to Present at BioCentury Future Leaders in the Biotech Industry ConferencHoward Williams-3/21/2014
222What we knew from the SEC filing yesterday is now "out" ... **********Howard Williams-3/19/2014
221It's worth noting that OMER is now trading at about 16% OVER its offering prHoward Williams-3/19/2014
220This just out ...... Entire offering and overallotment purchased Item 1.01 EntrHoward Williams-3/18/2014
219Using many of the same investment bankers/managers as OMER, another biotech ... Howard Williams-3/16/2014
218Omeros Prices $35.0 Million Public Offering of Common Stock SEATTLE, March 14,Howard Williams-3/14/2014
217Maybe I'm easy to please but I'm happy with OMER's progress on OmidrHoward Williams-3/13/2014
216You have to be careful here. Soliris is principally used for PNH, and unclear ifBiomaven13/11/2014
215Zeroing in on OMS721 and Alexion's Soliris: - Soliris, the only FDA-approveHoward Williams-3/11/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News